RU4476U1 - INDIVIDUAL INHALATOR - Google Patents

Abstract

1. An individual inhaler comprising a housing, a dispersion assembly and an air duct disposed in the housing, characterized in that it further comprises an air flow inducer installed in the housing connected to the dispersion assembly, a duration controller connected to the dispersion assembly and an air flow inducer, a flow regulator air connected to an air flow inducer, a power supply connected to a duration controller and an air flow regulator, an air valve connected first air filter and the second air valve is coupled via a tube with a mask (and / or mouthpiece), dispersing and node configured as a device for fine grinding salts, e.g. privodom.2 mill. The inhaler according to claim 1, characterized in that the housing further comprises an internal partition dividing the space of the housing into two parts, in one of which there is a dispersing unit, an air flow inducer, an air duct, an operating time regulator, an air flow regulator and a power supply, and the second is air valves, while both parts are interconnected through the outlet of the dispersion unit.

Description

Individual inhaler

The utility model relates to medicine, and more specifically to devices for inhalation of dry medicinal preparations in the form of powders, and can be used for individual therapeutic procedures in the treatment and prophylaxis of respiratory diseases both in medical institutions and at home.

Currently, for the treatment and prevention of respiratory diseases, the method of dry salt aerosol therapy is used, the implementation of which uses devices for obtaining dry salt aerosol. The most effective devices for this purpose are those that provide dry salt aerosol of a given concentration and allow it to be kept constant for a fairly long inhalation session (30-60 minutes). Such devices include, for example, a device for producing dry aerosol according to USSR patent No. 1793932 from 05.29.91. However, this device is intended for use in special treatment rooms (halochambers) mainly for group aerosol therapy. It contains a high-performance salt dispersion unit, a salt aerosol monitoring and control system and a ventilation system that ensure uniform concentration throughout the entire halochamber and maintain it at a given level. dusting and introducing into the human respiratory tract powdered drugs. It belongs to the state. Nasch) Imer, powder inhaler, described in the application for European patent No. 0237507 (publication date 09.16.87, MKI A61M15 / 00). This powder inhaler (see Fig. 1) consists of a housing 1 in which there is an inlet 2 for air intake and the following are installed: an outlet nozzle 3 with deflectors 4 for dispersing the powder aggregates; powder storage chamber 5; dispensing unit, consisting of a perforated diaphragm 6, which comes into a rotational movement under the influence of the patient’s breathing energy, and elastic scrapers 7 for uniformly applying powder to the diaphragm; pipeline 8 connecting the inlet, the metering unit and the nozzle. By the number of coincide; their signs described inhaler is the closest to the claimed utility model. The specified inhaler provides only a single, pulsed input into the respiratory organs of a portion of the drug, which must be specially prepared (dispersed, or encapsulated and thoroughly drained). Its use for individual salt aerosol therapy is difficult, since salt powder has high hygroscopicity and increased ability to aggregate. In addition, this ingestioner does not allow maintaining the concentration of the drug aerosol received by the patient at a given level.

for a sufficiently long session.

The task to which the claimed utility model is directed is to create a new design of an individual inhaler that provides long-term maintenance of a given endgration of dry salt aerosol.

The problem is solved by an individual inhaler containing a housing in which a dispersion unit is installed, made, for example, in the form of a mill with a drive, an air flow inducer connected by an air duct to the dispersion unit, and a duration controller, made, for example, in the form of a time relay, electrically connected with an air flow inducer and a drgspergfs assembly, an air flow regulator made, for example, in the form of a voltage regulator, electrically connected to an air flow actuator ear, a power supply regulator coupled to elekgricheski working and air flow control, air valves, air filter, tube, mask and / or the mouthpiece.

The inventive utility model differs from the prototype in the presence of additional features, such as an air flow inducer, a duration controller, an air flow regulator, a power supply unit, air valves, an air filter, a mask and / or mouthpiece, as well as a dispersion unit in the form of, for example, a mill with a drive into which coarse salt is loaded without preliminary fine grinding and drying. The dispersion unit can be 306 / BS5

complete and in the form of other devices for fine grinding of salt.

The listed essential features of the claimed utility model provide in all cases a technical result consisting in maintaining a given concentration of salt aerosol throughout the entire session of salt aerosol therapy conducted individually for each patient.

In the particular case of the utility model, the housing may contain an internal partition dividing the space of the housing into two parts, in one of which there is a dispersing unit, an air flow inducer, an air duct, an operating time regulator, an air flow regulator and a digest unit, and in the second air valves, while both parts are interconnected through the outlet of the dispersion unit.

With this form of execution of the utility model, an additional technical result is achieved, consisting in increasing the degree of supply of electrical circuits from salt particles.

The list of figures drawings.

In FIG. 1 shows a diagram of an individual powder atomizer (prototype).

On FRP. 2 shows a diagram of the inventive individual inhaler.

The inventive individual inhaler comprises a housing I, in which a dispersion unit 2 is installed, made, for example, in

in the form of a mill with drive, an air flow inducer 3, connected to a dispersion unit 2 by an air duct 6, a duration controller 4, made, for example, in the form of a timer, electrically connected to an air flow inducer 3 and a dispersion unit 2, an air flow regulator 5 made, for example, in the form of a voltage regulator, electrically connected to an air flow inducer 3, a power supply 12, electrically connected to a duration controller 4 and an air flow regulator 5, an air valve 7, connected to an air filter 9, and an air valve 8, connected through a pipe 10 with a mask (and / or mouthpiece) I. An individual inhaler operates as follows. Salt is loaded into the dispersion unit 2, the concentration of the generated salt aerosol required for this procedure is set on the air flow regulator 5, the duration of the therapeutic procedure is set by the duration controller 4, and the inhaler is connected to the network. In this case, the operating time controller 4 starts the dispersion unit 2 and the air flow inducer 3. The air flow from the air flow inducer 3 through the air duct 6 enters the dispersion unit 2 and discharges the crushed salt particles into the space of the housing 1 through its outlet, from where through the air valve 8, the pipe 10 and the mask (and / or mouthpiece) 11 due to the patient's breathing energy, dry salt aerosol enters the respiratory tract, where it has a therapeutic effect. Via air filter 9 and air valve 7

air enters into the housing 1 to prevent the formation of a vacuum zone.

Thus, when implementing a utility model, a technical result is achieved, which is expressed in ensuring that the concentration of dry salt aerosol is maintained at a given level for the time required for each specific therapeutic procedure. This, in turn, makes it possible to apply the method of salt aerosol therapy individually by each patient both in a medical institution and at home.

Claims (2)

1. An individual inhaler comprising a housing, a dispersion assembly and an air duct disposed in the housing, characterized in that it further comprises an air flow inducer installed in the housing connected to the dispersion assembly, a duration controller connected to the dispersion assembly and an air flow inducer, a flow regulator air connected to an air flow inducer, a power supply connected to a duration controller and an air flow regulator, an air valve connected first air filter and the second air valve is coupled via a tube with a mask (and / or mouthpiece), dispersing and node configured as a device for fine grinding salts, e.g. the mill drive. 2. The inhaler according to claim 1, characterized in that the housing further comprises an internal partition dividing the space of the housing into two parts, in one of which there is a dispersing unit, an air flow inducer, an air duct, an operating time regulator, an air flow regulator and a power supply, and in the second, air valves, with both parts communicating with each other through the outlet of the dispersion unit.